What does pharmaceutical facility design include?
Pharmaceutical facility design typically includes programming, master planning, process coordination, architectural design, building systems engineering, automation planning, EH&S considerations, and documentation support. For regulated environments, the design must also account for cGMP workflows, material and personnel movement, utility requirements, clean space needs, and future expansion so the facility can operate efficiently while supporting compliance objectives.
How early should we involve a pharmaceutical facility design firm?
The best time to involve a design firm is during early planning, before major site, equipment, or layout decisions are finalized. Early involvement helps define the URS, evaluate site constraints, align process needs with building systems, and identify compliance or permitting issues sooner. That usually leads to better budgeting, fewer redesigns, and a smoother path from concept through construction and startup.
Can Hixson support cGMP pharmaceutical projects?
Yes. Hixson states that it has been designing cGMP spaces for over 75 years and supports pharmaceutical and biotech clients from defining the URS through design. That experience is valuable for projects requiring coordinated planning across architecture, engineering, process needs, and regulated operational requirements, especially when teams need a single-source partner to reduce gaps between disciplines.
Do you provide master planning for pharmaceutical facilities in Indianapolis?
Yes. Master planning is one of Hixson's core integrated services and can help pharmaceutical clients in Indianapolis evaluate phased growth, site use, adjacencies, circulation, and long-term capacity. This is especially useful when planning a new facility, expanding an existing operation, or sequencing capital improvements while maintaining production continuity and preparing for future operational demands.
What is the benefit of using an integrated architecture and engineering firm?
An integrated firm brings architecture, engineering, process planning, and technical disciplines together under one team. That improves communication, reduces coordination gaps, and helps decisions move faster because key stakeholders are aligned from the start. For pharmaceutical projects, this approach can lower project risk, improve document consistency, and better connect facility design with operational and compliance requirements.
Can you help with controls and automation as part of facility design?
Yes. Hixson's Controls & Automation group supports projects from feasibility and front-end definition through programming, testing, startup, and commissioning. For pharmaceutical facilities, that can include network design, electrical control and panel design, PLC and HMI support, and coordination with broader facility systems so automation strategies align with production goals and building infrastructure.
Do pharmaceutical facility projects require EH&S and permitting support?
Most pharmaceutical facility projects benefit from early EH&S and permitting coordination because environmental, health, safety, and regulatory considerations can affect layout, utilities, equipment placement, and project timing. Hixson offers EH&S Compliance & Permitting as part of its integrated services, helping teams address these requirements during design rather than discovering conflicts later in the project lifecycle.
Does Hixson serve clients beyond Indianapolis?
Yes. Hixson serves clients throughout North America, while this page focuses on pharmaceutical facility design in Indianapolis. That broader reach means the firm brings experience from complex projects across multiple markets, while still applying local relevance to Indianapolis-area planning, stakeholder coordination, and facility strategies suited to Central Indiana's expanding life sciences and manufacturing environment.